1. Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement
- Author
-
Po Hu, Han Chen, Li-Han Wang, Ju-Bo Jiang, Jia-Min Li, Meng-Yao Tang, Yu-Chao Guo, Qi-Feng Zhu, Zhao-Xia Pu, Xin-Ping Lin, Stella Ng, Xian-Bao Liu, and Jian-An Wang
- Subjects
Transcatheter aortic valve replacement ,Mortality ,Natriuretic peptides ,NT-proCNP ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Unlike N-terminal pro-B-type natriuretic peptide (NT-proBNP), which have been extensively studied, little is known about the role of N-terminal pro-C-type natriuretic peptide (NT-proCNP) for predicting survival post transcatheter aortic valve replacement (TAVR). Methods A total of 309 patients were included in the analysis. Patients were grouped into quartiles (Q1–4) according to the baseline NT-proCNP value. Blood for NT-proCNP analysis was obtained prior to TAVR procedure. The primary endpoint was mortality after a median follow-up of 32 months. Multivariable Cox proportional hazards regression models analyzed prognostic factors. The predictive capability was compared between NT-proBNP and NT-proCNP using receiver operator curve (ROC) analysis. Results A total of 309 subjects with the mean age of 76.8 ± 6.3 years, among whom 58.6% were male, were included in the analysis. A total of 58 (18.8%) patients died during follow-up. Cox multivariable analyses indicated society of thoracic surgeons (STS)-score was a strong independent predictor for mortality (hazard ratio (HR) 1.08, 95% confidential interval (CI) 1.05–1.12, P
- Published
- 2022
- Full Text
- View/download PDF